Life After Thyroidectomy: Hormone, Calcium, Voice and Long-Term Follow-Up

Hemithyroidectomy (lobectomy): one lobe of the thyroid is removed. The contralateral lobe remains and continues to function. 60-70% of patients do not need post-operative levothyroxine; 30-40% develop subclinical or overt hypothyroidism and start low-dose replacement.

Total thyroidectomy: the entire gland is removed. Levothyroxine is required for life. Indications include thyroid cancer, multinodular goitre (large or compressive), Graves disease (refractory), or bilateral suspicious nodules.

Concurrent neck dissection: papillary thyroid cancers may have central (level VI) or lateral (levels II-V) nodal dissection. This alters the post-operative recovery and complication profile — particularly added risks for calcium metabolism and voice. Related service: our thyroid surgery programme.

After total thyroidectomy the starting dose averages 1.5-1.7 mcg/kg/day — about 100-125 mcg/day for a 70-kg patient. In the elderly or cardiac patients, start lower (50-75 mcg) and titrate over weeks. First TSH 6-8 weeks after initial dosing.

TSH target depends on the diagnosis. 1) Benign causes (multinodular goitre, Graves): 0.5-2.5 mIU/L. 2) Low-risk differentiated thyroid cancer: 0.1-0.5 mIU/L (mild suppression). 3) High-risk or persistent disease: <0.1 mIU/L (full suppression). Targets are individualised and stage-dependent.

Take levothyroxine on an empty stomach in the morning; wait 30-60 minutes before food. Iron, calcium, coffee, soy products, antacids and omeprazole reduce absorption — separate by at least 4 hours. Some patients prefer bedtime dosing 3-4 hours fasting — also acceptable.

Dose changes are made in 12.5-25 mcg increments. Don't panic over very small TSH shifts — assay variation exists. Real dose changes are confirmed by a repeat TSH.

The parathyroid glands sit on the posterior surface of the thyroid, 3-5 mm in size, usually four in number (sometimes five or more). During thyroidectomy their blood supply can be impaired or they may be inadvertently removed. The result: hypoparathyroidism → hypocalcaemia.

Transient hypocalcaemia occurs in 20-30% of patients in the first 24-48 hours. Peri-oral tingling, finger paraesthesia, muscle cramps, Chvostek and Trousseau signs. Treatment: oral or IV calcium gluconate + calcitriol. Most cases resolve as parathyroid function recovers over weeks.

Permanent hypoparathyroidism: still requiring calcium + calcitriol beyond 6 months. Risk is 1-3% in experienced hands, rising to 5-10% when neck dissection is added. Treatment: daily calcium carbonate 1-2 g + calcitriol 0.25-0.5 mcg; target serum calcium at the lower edge of normal (8.5-9.5 mg/dL).

Long-term hypoparathyroidism follow-up must screen for renal stones — annual urinary calcium and renal ultrasound. Magnesium deficiency may coexist and should be measured. Recombinant PTH (teriparatide) is an alternative in advanced cases.

The recurrent laryngeal nerve (RLN) runs behind the thyroid and supplies all motor innervation to the vocal cords. The risk of nerve injury during thyroidectomy is 1-3% permanent and 5-10% transient. The external branch of the superior laryngeal nerve controls high pitch; injury affects voice quality without full paralysis.

Unilateral RLN palsy: the same-side cord remains in open position. Voice is breathy and weak, mild aspiration risk during swallowing, vocal fatigue. 80-90% of transient cases recover in 3-6 months.

Bilateral RLN palsy (very rare, <1%): both cords sit closed. Breathing difficulty and stridor — may require emergency tracheostomy. This is life-threatening and is almost always recognised intraoperatively or immediately after.

Voice therapy (logopedics) is effective in both transient and permanent dysphonia. For permanent paralysis, injection medialisation (Cymetra, hydroxyapatite) or Type I thyroplasty provides durable voice improvement. Modern endoscopic techniques avoid large incisions. More detail: thyroidectomy page.

The classic thyroidectomy incision (Kocher) is 4-6 cm in the lower anterior neck, placed within a natural skin crease. With meticulous closure and post-op care, the scar is mildly visible at 1 year in most patients.

Scar care: keep the wound clean for the first 2 weeks; after suture removal use silicone gel or sheeting for 3-6 months. Sun protection (SPF 50+) is essential for the first year — pigmentation risk is high. Massage from week 3 onwards softens fibrosis.

Patients prone to hypertrophic scars or keloids (African heritage, younger age, tension areas) benefit from intralesional corticosteroid injection, silicone dressing, or selected laser therapy. This risk must be addressed preoperatively.

Minimally invasive and robotic techniques (transaxillary, retroauricular) avoid a visible neck incision in selected cases. Their suitability across all thyroid disease is debated; small benign nodules or hemithyroidectomy candidates are considered.

Exercise: light activity at 1 week, normal exercise at 2-3 weeks, heavy resistance training at 4-6 weeks. Swimming in a public pool after 2-3 weeks; diving after 6 weeks. Neck-stretching with a physiotherapist relaxes scar tissue.

Pregnancy planning: after thyroid cancer, wait at least 6-12 months (after TSH stabilises). In pregnancy, dose increases by 25-30% (add 2 extra doses per week as soon as pregnancy is confirmed). Monitor TSH every 4 weeks; target ≤2.5 mIU/L in the first trimester, ≤3.0 in later trimesters.

Nutrition: there is no special "thyroid diet" after thyroidectomy. Balanced eating, avoid iodine excess (iodine is no longer needed because the thyroid is absent), maintain calcium adequacy (supplement if necessary), annual screening for vitamin D deficiency.

Soy, cruciferous vegetables (broccoli, cauliflower, cabbage), milk thistle — popular claims of effects on hypothyroid patients have weak scientific support. Excessive restriction is not warranted. The key is to keep other foods away for 30-60 minutes after levothyroxine.

Differentiated thyroid cancer follow-up: serum thyroglobulin (Tg) and anti-Tg antibodies, neck ultrasound. Thyroglobulin is the unique marker of remaining thyroid tissue — it should not rise unless cancer recurs. Annual or 6-monthly, depending on stage.

In low-risk papillary microcancers (≤1 cm, organ-confined, node-negative) plain follow-up suffices. In high-risk disease, postoperative radioactive iodine (RAI) ablation destroys residual thyroid and microscopic metastases. Before RAI, a low-iodine diet and TSH elevation (either by withholding thyroxine or recombinant TSH) are required.

The modern trend is toward less aggressive treatment: most microcancers are managed with TSH suppression and surveillance without RAI. This is a more individualised approach than the older "RAI for all" stance.

Medullary thyroid cancer is a different tumour — followed with calcitonin and CEA. RET proto-oncogene mutation analysis is done (for familial syndromes). Anaplastic thyroid cancer is very aggressive; treatment is multidisciplinary and often palliative. We share patient experiences on our Istanbul thyroid surgery page.